Search

Abstract Background Lignin is a naturally occurring and aromatic biopolymer with well-known antimicrobial and antioxidant properties. Thus, in this work, the use of cellulose nanofibers (CNF) and lignin to produce ultra-light aerogels for biomedical applications was studied. Aerogels containing varying amounts of lignin (0–30 wt%) and different concentrations of the crosslinking agent Fe3+ (25–100 mM) were developed. Results The different bioaerogels were fully characterized and their physical, mechanical and bioactive properties analyzed. It was observed that the bioaerogels soluble fraction tends to decrease as the lignin content increases for the different Fe3+ concentrations, due to lignin–CNF interactions through hydrogen bonds. The bioaerogels containing lignin showed remarkable radical scavenging activity as the DPPH concentration decreased with time. This confirms the benefits of including lignin in bioaerogels to impart antioxidant properties. To study the suitability of the produced bioaerogels for controlled drug release, the release of tetracycline (TC) was studied. All of the bioaerogels released TC in a sustained manner for 6 h and presented similar profiles. However, the bioaerogels containing higher concentrations of crosslinker showed a higher release of TC. The TC loading conferred clear antimicrobial activity against S. aureus as expected, unlike the insignificant antimicrobial activity of the bioaerogels without TC. The biocompatibility of the samples was demonstrated for all materials produced (with and without TC loading) by the Kruskal–Wallis test with multiple comparisons. After observation of cell morphology, no significant differences were evident suggesting that the CNF–lignin bioaerogels present optimal biocompatibility for use in the biomedical and pharmaceutical industry. Conclusions The CNF–lignin bioaerogels presented in this work highlights their promising application as biomedical applications, such as wound dressings due to their biocompatibility, antimicrobial and antioxidant properties, as well as their swelling and solubility properties. Graphical Abstract

A review of our current knowledge of B cell antigen uptake mechanisms, the relevance of these processes to pathology, and outstanding questions in the field. Specific antigens induce B cell activation through the B cell receptor (BCR) which initiates downstream signaling and undergoes endocytosis. While extensive research has shed light on the signaling pathways in health and disease, the endocytic mechanisms remain largely uncharacterized. Given the importance of BCR-antigen internalization for antigen presentation in initiating adaptive immune responses and its role in autoimmunity and malignancy, understanding the molecular mechanisms represents critical, and largely untapped, potential therapeutics. In this review, we discuss recent advancements in our understanding of BCR endocytic mechanisms and the role of the actin cytoskeleton and post-translational modifications in regulating BCR uptake. We discuss dysregulated BCR endocytosis in the context of B cell malignancies and autoimmune disorders. Finally, we pose several outstanding mechanistic questions which will critically advance our understanding of the coordination between BCR endocytosis and B cell activation.